Biofrontera INC. (BFRIW) — S-1/A Filings
All S-1/A filings from Biofrontera INC.. Browse 3 S-1/A reports with AI-powered summaries and risk analysis.
S-1/A Filings (3)
-
Biofrontera Amends Ameluz Deal, Boosts Dosage, Divests Xepi
— Aug 13, 2025 Risk: high
Biofrontera Inc. (BFRIW) is a U.S.-based biopharmaceutical company focused on dermatological conditions, primarily photodynamic therapy (PDT) for actinic kerato -
Biofrontera Inc. Files Amendment No. 1 to Form S-1 Registration Statement
— Mar 20, 2024 Risk: low
Biofrontera Inc. (BFRIW) filed a Amended IPO Registration (S-1/A) with the SEC on March 20, 2024. Biofrontera Inc. filed an amendment (No. 1) to its Form S-1 Re -
Biofrontera Inc. Files S-1/A Amendment
— Jan 29, 2024 Risk: low
Biofrontera Inc. (BFRIW) filed a Amended IPO Registration (S-1/A) with the SEC on January 29, 2024. Biofrontera Inc. filed an S-1/A amendment on January 29, 202
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX